These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 7905325

  • 21. Autografting in chronic myeloid leukemia with cultured marrow: update of the Vancouver Study.
    Barnett MJ, Eaves CJ, Phillips GL, Hogge DE, Klingemann HG, Lansdorp PM, Nantel SH, Reece DE, Shepherd JD, Sutherland HJ.
    Stem Cells; 1993 Oct; 11 Suppl 3():64-6. PubMed ID: 7905324
    [Abstract] [Full Text] [Related]

  • 22. Autologous transplantation for chronic myelogenous leukemia with mafosfamide-treated marrow.
    Rizzoli V, Mangoni L, Almici C, Caramatti C, Dotti GP, Carlo-Stella C.
    Stem Cells; 1993 Oct; 11 Suppl 3():25-30. PubMed ID: 8298474
    [Abstract] [Full Text] [Related]

  • 23. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J, Wu B, Liu Q, Feng R, Liu X, Meng F, Zhou S.
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
    [Abstract] [Full Text] [Related]

  • 24. Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests.
    Janssen JJ, van Rijn RS, van der Holt B, Schuurhuis GJ, Vellenga E, Verhoef GE, Ossenkoppele GJ, van den Berg E, Hagemeijer A, Släter R, Nieuwint AW, Cornelissen JJ.
    Bone Marrow Transplant; 2000 Jun; 25(11):1147-55. PubMed ID: 10849527
    [Abstract] [Full Text] [Related]

  • 25. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
    Jiang Q, Chen SS, Jiang B, Jiang H, Lu Y, Qiu JY, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504
    [Abstract] [Full Text] [Related]

  • 26. Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens.
    Deininger M, Pönisch W, Krahl R, Leiblein S, Edel E, Lange T, Fiedler F, Freund M, Franke A, Pasold R, von Grünhagen U, Herold M, Dölken G, Hoffmann FA, Uhle R, Schultze W, Steglich J, Schwarzer A, Richter P, Winkelmann C, Kettner E, Dachselt K, Subert R, Schwalbe E, Doepper J, Helbig W, Niederwieser D, East German Study Group Haematology/Oncology (OSHO).
    Bone Marrow Transplant; 2001 Jun; 27(11):1125-32. PubMed ID: 11551022
    [Abstract] [Full Text] [Related]

  • 27. FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission.
    Deane M, Koh M, Foroni L, Galactowicz G, Hoffbrand AV, Lawler M, Secker-Walker L, Prentice HG.
    Bone Marrow Transplant; 1998 Dec; 22(12):1137-43. PubMed ID: 9894715
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of Philadelphia chromosome-negative cells in chronic myelogenous leukemia.
    Kantarjian HM, Talpaz M, LeMaistre CF, Spinolo J, Spitzer G, Yau J, Dicke K, Jagannath S, Deisseroth AB.
    Cancer; 1991 Jun 15; 67(12):2959-65. PubMed ID: 1675151
    [Abstract] [Full Text] [Related]

  • 36. [Autologous transplantation of Ph-negative peripheral blood stem cells for treatment of chronic myelogenous leukemia].
    Hatsuse M, Okano A, Okamoto A, Shimura K, Takahashi R, Hirai H, Ashihara E, Inaba T, Fujita N, Shimazaki C, Nakagawa M.
    Rinsho Ketsueki; 2000 Aug 15; 41(8):671-5. PubMed ID: 11020996
    [Abstract] [Full Text] [Related]

  • 37. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G, Lemoli R, Tosi P, Martinelli G, Testoni N, Ricci P, Motta M, Gherlinzoni F, Leopardi G, Pastano R, Rizzi S, Piccaluga P, Isidori A, Tura S.
    Bone Marrow Transplant; 1999 Sep 15; 24(5):467-72. PubMed ID: 10482929
    [Abstract] [Full Text] [Related]

  • 38. Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML.
    Fischer T, Neubauer A, Mohm J, Huhn D, Busemann C, Link H, Arseniev L, Büssing B, Novotny J, Ganser A, Duyster J, Bunjes D, Kreiter S, Aulitzky W, Hehlmann R, Huber C.
    Bone Marrow Transplant; 1998 May 15; 21(10):1029-36. PubMed ID: 9632277
    [Abstract] [Full Text] [Related]

  • 39. Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phase.
    Meloni G, De Fabritiis P, Alimena G, Malagnino F, Montefusco E, Sandrelli A, Pinto R, Vignetti M, Lo Coco F, Mandelli F.
    Bone Marrow Transplant; 1989 Dec 15; 4 Suppl 4():92-4. PubMed ID: 2576389
    [Abstract] [Full Text] [Related]

  • 40. Prognostic factors influencing feasibility of cytogenetic and molecular analysis in leukapheresis products in chronic myelogenous leukemia patients.
    Carrasco M, Sureda A, Martínez C, Carmona M, Altés A, Martín-Henao GA, Aventín A, Sierra J.
    Ann Hematol; 2002 Dec 15; 81(12):710-6. PubMed ID: 12483367
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.